Clinical characteristics and acute complication of COVID-19 patients with diabetes: a multicenter, retrospective study in Southern China
Xiao-Ying Zhou, Shao-Feng Huang, Jun-Xu Lin, Hai-Ni Zhi, Lu Xiao, Xiang-Zhu Wang, Kai-Heng Guo, Lin Zhou, Tao Long, Hui-Min You, Ming-Run Lin, Xiang-Ya Luo, Wei-Ping Sun, Chun-Ping Zeng
Frontiers in Endocrinology, doi:10.3389/fendo.2023.1237832
This study aims to describe the clinical characteristics, laboratory data and complications of hospitalized COVID-19 patients with type 2 diabetes mellitus (T2DM) since epidemic prevention and control optimization was adjusted in December 2022 in China. Methods: This retrospective multicenter study included 298 patients with confirmed type 2 diabetes mellitus with or without COVID-19. We collected data from the first wave of the pandemic in The Fifth Affiliated
Ethics statement The studies involving humans were approved by the Fifth Affiliated of Guangzhou Medical University Research Ethics Committee (GYWY-L2023-64). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.
Author contributions C-pZ and W-pS performed the general development and design of the study and contributed to critical revisions. X-yZ is the first author who contributed to the design, statistical analysis and manuscript writing of the study. S-fH wrote sections of the manuscript. S-fH, J-xL, H-nZ, LX, X-zW, K-hG, LZ, TL, H-mY, M-rL, and X-yL contributed to data collection and helped perform the analysis with constructive discussion. All authors contributed to the article and approved the submitted version.
Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Agyeman, Chin, Landersdorfer, Liew, Ofori-Asenso, Smell and taste dysfunction in patients with COVID-19: A systematic review and meta-analysis
Alguwaihes, Me, Megdad, Albader, Alsari et al., Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a singlecentre retrospective study, Cardiovasc Diabetol,
doi:10.1186/s12933-020-01184-4Bi, Zhang, Li, Kan, Li et al., Contributing factors of fatigue in patients with type 2 diabetes: A systematic review, Psychoneuroendocrinology,
doi:10.1016/j.psyneuen.2021.105280Bornstein, Rubino, Khunti, Mingrone, Hopkins et al., Practical recommendations for the management of diabetes in patients with
Carboni, Carta, Carboni, Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19? Med Hypotheses,
doi:10.1016/j.mehy.2020.109776Cariou, Hadjadj, Wargny, Pichelin, Al-Salameh et al., Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study, Diabetologia,
doi:10.1007/s00125-020-05180-xChen, Yang, Cheng, Chen, Peng et al., Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucoselowering medication, Diabetes Care,
doi:10.2337/dc20-0660Chu, Tsang, Tang, Lam, Lai et al., Soleimani M. Acute kidney injury in SARS-coV-2 infection: Direct effect of virus on kidney proximal tubule cells, Int J Mol Sci,
doi:10.3390/ijms21093275Conway, Gould, Westley, Raju, Oklopcic et al., Characteristics of patients with diabetes hospitalised for COVID-19 infection-a brief case series report, Diabetes Res Clin Pract,
doi:10.1016/j.diabres.2020.108460Glaser, Kruger, Merkel, Bramlage, Herth, Chronic obstructive pulmonary disease and diabetes mellitus: a systematic review of the literature, Respiration,
doi:10.1159/000369863Guo, Li, Dong, Zhou, Zhang et al., Diabetes is a risk factor for the progression and prognosis of COVID-19, Diabetes Metab Res Rev,
doi:10.1002/dmrr.3319Hamming, Timens, Bulthuis, Lely, Navis et al., Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J Pathol,
doi:10.1002/path.1570Hoier, Chaaban, Andersen, Possibilities for maintaining appetite in recovering COVID-19 patients, Foods,
doi:10.3390/foods10020464Kamrath, Monkemoller, Biester, Rohrer, Warncke et al., Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany, JAMA,
doi:10.1001/jama.2020.13445Klein, Smith, Tipping, Peng, Williams, Reduced diffusion lung capacity in patients with type 2 diabetes mellitus predicts hospitalization for pneumonia, Diabetes Res Clin Pract,
doi:10.1016/j.diabres.2010.12.012Li, Bai, Hashikawa, The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients, J Med Virol,
doi:10.1002/jmv.25728Li, Wang, Chen, Zuo, Zhang et al., COVID-19 infection may cause ketosis and ketoacidosis, Diabetes Obes Metab,
doi:10.1111/dom.14057Mcgurnaghan, Weir, Bishop, Kennedy, Blackbourn et al., Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland, Lancet Diabetes Endocrinol,
doi:10.1016/S2213-8587(20)30405-8Mithal, Jevalikar, Sharma, Singh, Farooqui et al., High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes, Diabetes Metab Syndr,
doi:10.1016/j.dsx.2020.12.029Muller, Gross, Conzelmann, Kruger, Merle et al., SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas, Nat Metab,
doi:10.1038/s42255-021-00347-1Nguyen, Ho, Nguyen, Ho, Li et al., Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis, Metabolism,
doi:10.1016/j.metabol.2022.155196Pelle, Zaffina, Provenzano, Moirano, Arturi, COVID-19 and diabetes-Two giants colliding: From pathophysiology to management, Front Endocrinol (Lausanne),
doi:10.3389/fendo.2022.974540Rayman, Lumb, Kennon, Cottrell, Nagi et al., Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID-19 pandemic, Nat Rev Endocrinol,
doi:10.1038/s41574-020-00435-4Renzo, Gualtieri, Pivari, Soldati, Attina et al., Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey, J Transl Med,
doi:10.1186/s12967-020-02399-5Richardson, Hirsch, Narasimhan, Crawford, Mcginn et al., Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area, JAMA,
doi:10.1001/jama.2020.6775Santi, Zoppini, Locatelli, Finocchio, Cappa et al., Type 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population, BMC Pulm Med,
doi:10.1186/s12890-017-0443-1Shi, Zhang, Jiang, Zhang, Hu et al., Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: A two-center, retrospective study, Diabetes Care,
doi:10.2337/dc20-0598Sinha, Cheng, Schaffer, Aldape, Schiff et al., In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression, Mol Syst Biol,
doi:10.15252/msb.20209628Stewart, Role of exercise training on cardiovascular disease in persons who have type 2 diabetes and hypertension, Cardiol Clin,
doi:10.1016/j.ccl.2004.06.007Tian, Nie, Sun, Ye, The epidemiological features of the SARS-CoV-2 omicron subvariant BA.5 and its evasion of the neutralizing activity of vaccination and prior infection, Vaccines (Basel),
doi:10.3390/vaccines10101699Vieira, Souto, Sanchez-Lopez, Machado, Severino et al., Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome-strategies for in Vivo administration: Part-II, J Clin Med,
doi:10.3390/jcm8091332Wang, Du, Zhu, Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients, Diabetes Res Clin Pract,
doi:10.1016/j.diabres.2020.108214Wang, Gao, Zhang, Huang, Zhang et al., Prevalence and ethnic pattern of diabetes and prediabetes in China, JAMA,
doi:10.1001/jama.2017.7596Wu, Lidsky, Lee, Cheng, Nakayama, SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment, Cell Metab,
doi:10.1016/j.cmet.2021.05.013Yan, Yang, Wang, Ren, Zhang et al., Clinical characteristics and outcomes of patients with severe covid-19 with diabetes, BMJ Open Diabetes Res Care,
doi:10.1136/bmjdrc-2020-001343
